Advances in fertility preservation for women undergoing cancer treatment: from cryopreservation to novel therapies
Reproduction · 04.11.2026 · 172 (5)
DOI: 10.1093/reprod/xaag123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproduction, online erschienen am 14.10.2026. Verfasst von Raquel Antolín und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Zaragoza, Zaragoza, Spain. Hauptthemen laut MEDLINE: Fertility Preservation, Cryopreservation, Neoplasms, Ovary. Die Arbeit nennt 96 Literaturangaben.
Abstract (Originalsprache)
In brief: Advances in cancer treatment have markedly improved survival rates, making fertility preservation an essential component of comprehensive care for children, adolescents, and young adults at risk of treatment-induced infertility. This Review summarizes current fertility preservation strategies, highlights recent advances in ovarian tissue cryopreservation, and discusses emerging approaches that may expand reproductive options for patients who cannot benefit from conventional techniques. Abstract: Advances in oncology have significantly improved survival, particularly among children and adolescents with cancer. However, many anticancer treatments are gonadotoxic and pose a significant risk to future fertility, with important psychosocial consequences for both patients and their families. Fertility preservation should therefore be addressed at diagnosis and prior to treatment initiation. Established strategies include embryo and mature oocyte preservation; however, these options are not feasible for prepubertal patients or for those requiring immediate chemotherapy. In such cases, ovarian tissue cryopreservation with autotransplantation following remission represents the only available option. This approach can restore both endocrine and fertility. Once considered experimental, ovarian tissue cryopreservation is now considered an established technique, however further optimization is required to improve efficacy and long-term outcomes, as well as to develop alternative strategies for utilizing tissue unsuitable for transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Zaragoza, Zaragoza, Spain.
- Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
- Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.
- Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.
- Centre for Reproductive Health, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh, United Kingdom.
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
ORCID-Profile: Evelyn Elizabeth Telfer, Clara Malo
Zitieren
APA
Antolín, R., Gargallo-Alonso, M., Lacueva-Aparicio, A., Telfer, E. E., Ochoa, I., & Malo, C. (2026). Advances in fertility preservation for women undergoing cancer treatment: from cryopreservation to novel therapies. Reproduction, 172(5). https://doi.org/10.1093/reprod/xaag123
Vancouver
Antolín R, Gargallo-Alonso M, Lacueva-Aparicio A, Telfer EE, Ochoa I, Malo C. Advances in fertility preservation for women undergoing cancer treatment: from cryopreservation to novel therapies. Reproduction. 2026;172(5). doi:10.1093/reprod/xaag123
BibTeX
@article{Antoln2026,
author = {Antolín, Raquel and Gargallo-Alonso, Marta and Lacueva-Aparicio, Alodia and Telfer, Evelyn Elizabeth and Ochoa, Ignacio and Malo, Clara},
title = {Advances in fertility preservation for women undergoing cancer treatment: from cryopreservation to novel therapies},
journal = {Reproduction},
year = {2026},
volume = {172},
number = {5},
doi = {10.1093/reprod/xaag123}
}
EUVIMED